Ratchets and clocks: The cell cycle, ubiquitylation and protein turnover

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 11, 2003, Pages 855-864

  Reed, Steven I ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN E; CYCLINE; PROTEASOME; PROTEIN CDC4; PROTEIN P130; STEM CELL FACTOR; UBIQUITIN; UNCLASSIFIED DRUG;

CELL CYCLE; ENZYME SUBSTRATE COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL CLOCKS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN E; F-BOX PROTEINS; HUMANS; NEOPLASMS; PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 0242551536     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1246     Document Type: Review

References (130)

1. Evans, T., Rosenthal, E. Z., Youngblom, J., Distel, D. & Hunt, T. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell 33, 389-396 (1983).This was the original paper describing regulated proteolysis of cyclin as a function of cell-cycle progression. These observations were largely responsible for Tim Hunt receiving the Nobel Prize.
2. Hershko, A. Ubiquitin: roles in protein modification and breakdown. Cell 34, 11-12 (1983).
3. Schimke, R. T. & Doyle, D. Control of enzyme levels in animal tissues. Annu. Rev. Biochem. 39, 929-976 (1970).
4. Rossow, P. W., Riddle, V. G. & Pardee, A. B. Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc. Natl Acad. Sci. USA 76, 4446-4450 (1979).
5. Glotzer, M., Murray, A. W. & Kirschner, M. W. Cyclin is degraded by the ubiquitin pathway. Nature 349, 132-138 (1991). Shows that cyclins are degraded by the ubiquitin-proteasome pathway and defines the D-box degron.
6. Nugroho, T. T. & Mendenhall, M. D. An inhibitor of yeast cyclin-dependent protein kinase plays an important role in ensuring the genomic integrity of daughter cells. Mol. Cell. Biol. 14, 3320-3328 (1994).
7. Donovan, J. D., Toyn, J. H., Johnson, A. L. & Johnston, L. H. P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae. Genes Dev. 8, 1640-1653 (1994).
8. Toyn, J. H., Johnson, A. L., Donovan, J. D., Toone, W. M. & Johnston, L. H. The Swl5 transcription factor of Saccharomyces cerevisiae has a role in exit from mitosis through induction of the cdk-inhibitor Sic1 in telophase. Genetics 145, 85-96 (1997)
9. Schwob, E., Bohm, T., Mendenhall, M. D. & Nasmyth, K. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae. Cell 79, 233-244 (1994). Shows how regulated proteolysis of the Cdk inhibitor Sic1 controls the G1-S transition.
10. Verma, R. et al. Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase. Science 278, 455-460 (1997).
11. Lengronne, A. & Schwob, E. The yeast CDK inhibitor Sic1 prevents genomic instability by promoting replication origin licensing in late G(1). Mol. Cell 9, 1067-1078 (2002).
12. Coats, S., Flanagan, W. M., Nourse, J. & Roberts, J. M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877-880 (1996).
13. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M. & Massague, J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260, 538-539 (1993).
14. Hengst, L. & Reed, S. I. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227, 25-41 (1998).
15. Harper, J. W. & Elledge, S. J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6, 56-64 (1996).
16. Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biol. 1, 193-199 (1999).
17. Montagnoli, A. et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13, 1181-1189 (1999).
18. Shirane, M. et al. Downregulation of p27 (Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J. Biol. Chem. 274, 13886-13893 (1999).
19. Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H. & Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661-664 (1999).
20. Erlandsson, F., Linnman, C., Ekholm, S., Bengtsson, E. & Zetterberg, A. A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells. Exp. Cell Res. 259, 86-95 (2000).
21. Harper, J. W. et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400 (1995).
22. Sherr, C. J. & Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163 (1995).
23. Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
24. Classon, M. & Dyson, N. p107 and p130: versatile proteins with interesting pockets. Exp Cell Res. 264, 135-147 (2001).
25. Claudio, P. P., Tonini, T. & Giordano, A. The retinoblastoma family: twins or distant cousins? Genome Biol. 3, reviews 3012 (2002).
26. Cip1 ubiquitination. Mol. Cell 5, 403-410 (2000).
27. Skp2. Genes Dev. 16, 2946-2957 (2002).
28. Sikp2 ubiquitin ligase in the degradation of p21Cip1 during S-phase. J. Biol. Chem. (2003).
29. Bloom, J. & Pagano, M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41-47 (2003).
30. Sandhu, C. & Slingerland, J. Deregulation of the cell cycle in cancer. Cancer Detect. Prev. 24, 107-118 (2000).
31. Slingerland, J. & Pagano, M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183, 10-17 (2000).
32. Nasmyth, K. Segregating sister genomes: the molecular biology of chromosome separation. Science 297, 559-565 (2002).
33. Agarwal, R. & Cohen-Fix, O. Mitotic regulation: the fine tuning of separase activity. Cell Cycle 1, 255-257 (2002).
34. Ciosk, R. et al. An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast. Cell 93, 1067-1076 (1998).
35. Jensen, S., Segal, M., Clarke, D. J. & Reed, S. I. A novel role of the budding yeast separin Esp1 in anaphase spindle elongation: evidence that proper spindle association of Esp1 is regulated by Pds1. J. Cell Biol. 152, 27-40 (2001).
36. Yamamoto, A., Guacci, V. & Koshland, D. Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae. J. Cell Biol. 133, 85-97 (1996).
37. Jallepalli, P. V. et al. Securin is required for chromosomal stability in human cells. Cell 105, 445-457 (2001).
38. Irniger, S. Cyclin destruction in mitosis: a crucial task of Cdc20. FEBS Lett. 532, 7-11 (2002).
39. Morgan, D. O. Regulation of the APC and the exit from mitosis. Nature Cell Biol. 1, E47-E53 (1999).
40. Townsley, F. M. & Ruderman, J. V. Proteolytic ratchets that control progression through mitosis. Trends Cell Biol. 8, 238-244 (1998).
41. Schwab, M., Lutum, A. S. & Seufert, W. Yeast Hct1 is a regulator of Clb2 cyclin proteolysis. Cell 90, 683-693 (1997).
42. Visintin, R., Prinz, S. & Amon, A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278, 460-463 (1997). Shows the activation of APC/C by alternative cofactors Cdc20 and Cdh1.
43. Lei, M. & Tye, B. K. Initiating DNA synthesis: from recruiting to activating the MCM complex. J. Cell Sci. 114, 1447-1454 (2001).
44. Nishitani, H. & Lygerou, Z. Control of DNA replication licensing in a cell cycle. Genes Cells 7, 523-534 (2002).
45. Woo, R. A., & Poon, R. Y. Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2, 316-324 (2003).
46. Keyomarsi, K. & Herliczek, T. W. The role of cyclin E in cell proliferation, development and cancer. Prog. Cell Cycle Res. 3, 171-191 (1997).
47. Donnellan, R. & Chetty, R. Cyclin E in human cancers, FASEB J. 13, 773-780 (1999).
48. Dulic, V., Lees, E. & Reed, S. I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257, 1958-1961 (1992).
49. Koff, A. et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257, 1689-1694 (1992).
50. Ekholm, S. V., Zickert, P., Reed, S. I. & Zetterberg, A. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol. Cell. Biol. 21, 3256-3265 (2001).
51. Lew, D. J., Dulic, V. & Reed, S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66, 1197-1206 (1991).
52. Won, K. A. & Reed, S. I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15, 4182-4193 (1996).
53. Clurman, B. E., Sheaff, R. J., Thress, K., Groudine, M. & Roberts, J. M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10, 1979-1990 (1996).
54. Fbw7 ubiquitin ligase. Science 294, 173-177 (2001).
55. Moberg, K. H., Bell, D. W., Wahrer, D. C., Haber, D. A. & Hariharan, I. K. Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413, 311-316 (2001).
56. Strohmaier, H. et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413, 316-322 (2001). References 54-56 show that cyclin E is targeted for proteolysis by an SCF ligase containing an F-box protein homologous to yeast Cdc4.
57. Spruck, C. et al. hCDC4 gene mutations in endometrial cancer. Cancer Res. 62, 4535-4539 (2002). Shows that Cdc4 in humans is a true tumour suppressor.
58. Spruck, C. H., Won, K. A. & Reed, S. I. Deregulated cyclin E induces chromosome instability. Nature 401, 297-300 (1999).
59. Brandeis, M. & Hunt, T. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J. 15, 5280-5289 (1996).
60. Zachariae, W., Schwab, M., Nasmyth, K. & Seufert, W. Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science 282, 1721-1724 (1998).
61. Kramer, E. R., Scheuringer, N., Podtelejnikov, A. V., Mann, M. & Peters, J. M. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol. Biol. Cell 11, 1555-1569 (2000).
62. Golan, A., Yudkovsky, Y. & Hershko, A. The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J. Biol. Chem. 277, 15552-15557 (2002).
63. Rudner, A. D. & Murray, A. W. Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphase-promoting complex. J. Cell Biol. 149, 1377-1390 (2000).
64. Fang, G., Yu, H. & Kirschner, M. W. Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol. Cell 2, 163-171 (1998).
65. Musacchio, A. & Hardwick, K. G. The spindle checkpoint: structural insights into dynamic signalling. Nature Rev. Mol. Cell Biol. 3, 731-741 (2002).
66. Pfleger, C. M. & Kirschner, M. W. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev. 14, 655-665 (2000). Compares the two APC/C degron motifs, the D-box and the KEN-box.
67. Prinz, S., Hwang, E. S., Visintin, R. & Amon, A. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis. Curr. Biol. 8, 750-760 (1998).
68. Shirayama, M., Zachariae, W., Ciosk, R. & Nasmyth, K. The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae. EMBO J. 17, 1336-1349 (1998).
69. Lukas, C. et al. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 401, 815-818 (1999).
70. Jaspersen, S. L., Chades, J. F. & Morgan, D. O. Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr. Biol. 9, 227-236 (1999).
71. Burton, J. L. & Solomon, M. J. D box and KEN box motifs in budding yeast Hsl1p are required for APC-mediated degradation and direct binding to Cdc20p and Cdh1p. Genes Dev. 15, 2381-2395 (2001).
72. Gieffers, C., Dube, P., Harris, J. R., Stark, H. & Peters, J. M. Three-dimensional structure of the anaphase-promoting complex. Mol. Cell 7, 907-913 (2001).
73. Zachariae, W. et al. Mass spectrometric analysis of the anaphase-promoting complex from yeast: identification of a subunit related to cullins. Science 279, 1216-1219 (1998). Describes a mass spectrometric analysis of the yeast APC/C that defines the constituent subunits.
74. Grr1 and Rbx1. Science 284, 662-665 (1999).
75. Seol, J. H. et al. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev. 13, 1614-1626 (1999).
76. Ohta, T., Michel, J. J., Schottelius, A. J. & Xiong, Y. ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity. Mol. Cell 3, 535-541 (1999).
77. Yoon, H. J. et al. Proteomics analysis identifies new components of the fission and budding yeast anaphase-promoting complexes. Curr. Biol. 12, 2048-2054 (2002).
78. Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263-274 (1996). Defines the F-box motif.
79. Cenciarelli, C. et al. Identification of a family of human F-box proteins. Curr. Biol. 9, 1177-1179 (1999).
80. Winston, J. T., Koepp, D. M., Zhu, C., Elledge, S. J. & Harper, J. W. A family of mammalian F-box proteins. Curr. Biol. 9, 1180-1182 (1999).
81. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209-219 (1997).
82. Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221-230 (1997). References 81 and 82 show the first in vitro reconstitution of active SCF.
83. Verma, R., Feldman, R. M. & Deshaies, R. J. SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities. Mol. Biol. Cell 8, 1427-1437 (1997).
84. Patton, E. E. et al. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box protein complexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev. 12, 692-705 (1998).
85. Li, F. N. & Johnston, M. Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J. 16, 5629-5638 (1997).
86. Kaiser, P., Sia, R. A., Bardes, E. G., Lew, D. J. & Reed, S. I. Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1. Genes Dev. 12, 2587-2597 (1998).
87. Met30-mediated control of the transcriptional activator Met4 is required for the G(1)-S transition. EMBO J. 19, 1613-1624 (2000).
88. Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo. Dev. Cell 4, 799-812 (2003).
89. βTrCP/Slimp ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase. Dev. Cell 4, 813-826 (2003).
90. Schulman, B. A. et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408, 381-386 (2000).
91. Skp2.
92. Kip1. Mol. Cell 7, 639-650 (2001).
93. Skp2-mediated ubiquitinylation of p27. Nature Cell Biol. 3, 321-324 (2001).
94. Cdc4 ubiquitin ligase. Cell 112, 243-256 (2003). Describes the X-ray crystallographic structure of Cdc4 bound to a phosphodegron peptide.
95. Gagne, J. M., Downes, B. P., Shiu, S. H., Durski, A. M. & Vierstra, R. D. The F-box subunit of the SCF E3 complex is encoded by a diverse superfamily of genes in Arabidopsis. Proc. Natl Acad. Sci. USA 99, 11519-11524 (2002).
96. CDC4 ubiquitin-ligase complex. Mol. Biol. Cell 11, 915-927 (2000).
97. Henchoz, S. et al. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast. Genes Dev. 11, 3046-3060 (1997).
98. Oberg, C. et al. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J. Biol. Chem. 276, 35847-35853 (2001).
99. Gupta-Rossi, N. et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem 276, 34371-34378 (2001).
100. Drury, L. S., Perkins, G. & Diffley, J. F. The Cdc4/34/53 pathway targets Cdc6p for proteolysis in budding yeast. EMBO J. 16, 5966-5976 (1997).
101. Hartwell, L. H., Culotti, J., Pringle, J. R. & Reid, B. J. Genetic control of the cell division cycle in yeast. Science 183, 46-51 (1974).
102. Hubbard, E. J., Wu, G., Kitajewski, J. & Greenwald, I. sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev 11, 3182-3193 (1997).
103. Nash, P. et al. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 414, 514-521 (2001). Describes how multiple inefficient Cdc4 degrons in Sic1 can be used to set a threshold linking phosphorylation to ubiquitylation and turnover.
104. Teicher, B. A., Ara, G., Herbst, R., Palombella, V. J. & Adams, J. The proteasome inhibitor PS-341 in cancer therapy. Clin. Cancer Res. 5, 2638-2645 (1999).
105. Zou, H., McGarry, T. J., Bernal, T. & Kirschner, M. W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418-422 (1999).
106. Cdc20 promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature 402, 203-207 (1999).
107. Dawson, I. A., Roth, S. & Artavanis-Tsakonas, S. The Drosophila cell cycle gene fizzy is required for normal degradation of cyclins A and B during mitosis and has homology to the CDC20 gene of Saccharomyces cerevisiae. J. Cell Biol. 129, 725-737 (1995).
108. Sigrist, S., Jacobs, H., Stratmann, R. & Lehner, C. F. Exit from mitosis is regulated by Drosophila fizzy and the sequential destruction of cyclins A, B and B3. EMBO J. 14, 4827-4838 (1995).
109. Sudakin, V. et al. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell 6. 185-197 (1995).
110. King, R. W. et al. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81, 279-288 (1995).
111. Yu, H., King, R. W., Peters, J. M. & Kirschner, M. W. Identification of a novel ubiquitin-conjugating enzyme involved in mitotic cyclin degradation. Curr. Biol. 6, 455-466 (1996).
112. Kramer, E. R., Gieffers, C., Holzl, G., Hengstschlager, M. & Peters, J. M. Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family. Curr. Biol. 8, 1207-1210 (1998).
113. Charles, J. F. et al. The Polo-related kinase Cdc5 activates and is destroyed by the mitotic cyclin destruction machinery in S. cerevisiae. Curr. Biol. 8, 497-507 (1998).
114. Castro, A. et al. APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep. 3, 457-462 (2002).
115. Taguchi, S. et al. Degradation of human Aurora-A protein kinase is mediated by hCdh1. FEBS Lett. 519, 59-65 (2002).
116. Ferreira, M. F., Santocanale, C., Drury, L. S. & Diffley, J. F. Dbf4p, an essential S phase-promoting factor, is targeted for degradation by the anaphase-promoting complex. Mol. Cell Biol. 20, 242-248 (2000).
117. Juang, Y. L. et al. APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle. Science 275, 1311-1314 (1997).
118. Petersen, B. O. et al. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev. 14, 2330-2343 (2000).
119. Bastians, H., Topper, L. M., Gorbsky, G. L. & Ruderman, J. V. Cell cycle-regulated proteolysis of mitotic target proteins. Mol. Biol. Cell 10, 3927-3941 (1999).
120. McGarry, T. J. & Kirschner, M. W. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93, 1043-1053 (1998).
121. Cdh1 and a bipartite destruction sequence. Mol. Biol. Cell 12, 3402-3416 (2001).
122. Gordon, D. M. & Roof, D. M. Degradation of the kinesin Kip1p at anaphase onset is mediated by the anaphase-promoting complex and Cdc20p. Proc. Natl Acad. Sci. USA 98, 12515-12520 (2001).
123. Funabiki, H. & Murray, A. W. The Xenopus chromokinesin Xkid is essential for metaphase chromosome alignment and must be degraded to allow anaphase chromosome movement. Cell 102, 411-424 (2000).
124. Burton, J. L. & Solomon, M. J. Hsl1p, a Swe1p inhibitor, is degraded via the anaphase-promoting complex. Mol. Cell Biol. 20, 4614-4625 (2000).
125. Kominami, K. & Toda, T. Fission yeast WD-repeat protein pop1 regulates genome ploidy through ubiquitin-proteasome-mediated degradation of the CDK inhibitor Rum1 and the S-phase initiator Cdc18. Genes Dev. 11, 1548-1560 (1997).
126. Wolf, D. A., McKeon, F. & Jackson, P. K. F-box/WD-repeat proteins pop1p and Sud1p/Pop2p form complexes that bind and direct the proteolysis of cdc18p. Curr. Biol. 9, 373-376 (1999).
127. Grr1 complex. EMBO J. 17, 5360-5373 (1998).
128. Bhattacharya, S. et al. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 22, 2443-2451 (2003).
129. Mendez, J. et al. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol. Cell 9, 481-491 (2002).
130. Ayad, N. G. et al. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113, 101-113 (2003).